Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Cash from Investing Activities: 2016-2025

Historic Cash from Investing Activities for Collegium Pharmaceutical (COLL) over the last 9 years, with Sep 2025 value amounting to -$30.9 million.

  • Collegium Pharmaceutical's Cash from Investing Activities rose 87.60% to -$30.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$55.2 million, marking a year-over-year increase of 81.66%. This contributed to the annual value of -$287.8 million for FY2024, which is 306.37% down from last year.
  • Collegium Pharmaceutical's Cash from Investing Activities amounted to -$30.9 million in Q3 2025, which was down 958.94% from -$2.9 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Cash from Investing Activities registered a high of -$113,000 during Q3 2022, and its lowest value of -$572.2 million during Q1 2022.
  • Over the past 3 years, Collegium Pharmaceutical's median Cash from Investing Activities value was -$11.8 million (recorded in 2024), while the average stood at -$36.5 million.
  • Per our database at Business Quant, Collegium Pharmaceutical's Cash from Investing Activities tumbled by 133,586.21% in 2022 and then skyrocketed by 99.97% in 2023.
  • Quarterly analysis of 5 years shows Collegium Pharmaceutical's Cash from Investing Activities stood at -$515,000 in 2021, then slumped by 82.52% to -$940,000 in 2022, then tumbled by 2,569.89% to -$25.1 million in 2023, then surged by 53.13% to -$11.8 million in 2024, then soared by 87.60% to -$30.9 million in 2025.
  • Its Cash from Investing Activities was -$30.9 million in Q3 2025, compared to -$2.9 million in Q2 2025 and -$9.7 million in Q1 2025.